Integral Health Asset Management, LLC Arcturus Therapeutics Holdings Inc. Transaction History

Integral Health Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$13.05 - $22.13 $346,516 - $587,617	-26,553 Reduced 16.96%	130,000 $1.93 Million
Q2 2022 Aug 03, 2022	BUY	$12.26 - $31.17 $386,839 - $983,507	31,553 Added 25.24%	156,553 $2.46 Million
Q1 2022 May 12, 2022	BUY	$17.64 - $39.57 $1.06 Million - $2.37 Million	60,000 Added 92.31%	125,000 $3.37 Million
Q4 2021 Feb 02, 2022	SELL	$34.2 - $47.56 $684,000 - $951,200	-20,000 Reduced 23.53%	65,000 $2.41 Million
Q3 2021 Nov 12, 2021	BUY	$27.88 - $58.25 $2.37 Million - $4.95 Million	85,000 New	85,000 $4.06 Million

174

25.3M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $457M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.